Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 09:41 am Purchase | 2023-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Polar Capital Holdings Plc | 3,135,871 5.730% | 3,135,871![]() (New Position) | Filing History |
| 2024-02-13 09:40 am Purchase | 2023-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 6,751,782 7.510% | 4,251,782![]() (+170.07%) | Filing History |
| 2024-02-13 09:39 am Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Polar Capital Holdings Plc | 500,000 1.050% | 342,552![]() (+217.57%) | Filing History |
| 2024-02-13 09:39 am Sale | 2023-12-31 | 13G | REVANCE THERAPEUTICS INC RVNC | Polar Capital Holdings Plc | 3,169,239 3.600% | -1,679,394![]() (-34.64%) | Filing History |
| 2024-02-13 09:27 am Purchase | 2023-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Polar Capital Holdings Plc | 3,975,000 8.260% | 196,269![]() (+5.19%) | Filing History |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 6,297,688 6.670% | -820,256![]() (-11.52%) | Filing History |
| 2023-11-16 1:13 pm Purchase | 2023-10-20 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 7,117,944 7.560% | 7,117,944![]() (New Position) | Filing History |
| 2023-07-28 09:01 am Purchase | 2023-07-19 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Polar Capital Holdings Plc | 157,448 5.020% | 157,448![]() (New Position) | Filing History |
| 2023-07-13 1:43 pm Unchanged | 2022-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Polar Capital Holdings Plc | 3,778,731 8.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | SUMMIT THERAPEUTICS INC SMMT | Polar Capital Holdings Plc | 0 0.000% | -6,295,713![]() (Position Closed) | Filing History |
| 2023-02-14 4:02 pm Purchase | 2022-12-31 | 13G | REVANCE THERAPEUTICS INC RVNC | Polar Capital Holdings Plc | 4,848,633 5.900% | 4,848,633![]() (New Position) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | QUOTIENT LIMITED QTNT | Polar Capital Holdings Plc | 0 0.000% | -231,291![]() (Position Closed) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Polar Capital Holdings Plc | 3,778,731 8.100% | 3,778,731![]() (New Position) | Filing History |
| 2023-02-14 3:59 pm Sale | 2022-12-31 | 13G | INFINITY PHARMACEUTICALS INC C INFIQ | Polar Capital Holdings Plc | 2,071,242 2.300% | -2,928,758![]() (-58.58%) | Filing History |
| 2022-02-14 10:58 am Sale | 2021-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 2,500,000 2.400% | -294,673![]() (-10.54%) | Filing History |
| 2022-02-14 10:47 am Purchase | 2021-12-31 | 13G | SUMMIT THERAPEUTICS INC SMMT | Polar Capital Holdings Plc | 6,295,713 6.400% | 495,713![]() (+8.55%) | Filing History |
| 2022-02-14 10:46 am Unchanged | 2021-12-31 | 13G | QUOTIENT LIMITED QTNT | Polar Capital Holdings Plc | 231,291 9.040% | 0 (Unchanged) | Filing History |
| 2022-02-14 10:46 am Sale | 2021-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Polar Capital Holdings Plc | 0 0.000% | -2,568,385![]() (Position Closed) | Filing History |
| 2022-02-14 10:41 am Purchase | 2021-12-31 | 13G | INFINITY PHARMACEUTICALS INC C INFIQ | Polar Capital Holdings Plc | 5,000,000 5.600% | 5,000,000![]() (New Position) | Filing History |
| 2022-02-14 10:40 am Sale | 2021-12-31 | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 2,794,673 4.800% | -233,032![]() (-7.70%) | Filing History |

